Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV

ABSTRACT Few studies have comprehensively compared severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-induced and hybrid B- and T-cell responses in people with HIV (PWH) to those in comparable controls without HIV. We included 195 PWH and 246 comparable controls from the AGEhIV COV...

Description complète

Détails bibliographiques
Auteurs principaux: Myrthe L. Verburgh, Lisa van Pul, Marloes Grobben, Anders Boyd, Ferdinand W. N. M. Wit, Ad C. van Nuenen, Karel A. van Dort, Khadija Tejjani, Jacqueline van Rijswijk, Margreet Bakker, Lia van der Hoek, Maarten F. Schim van der Loeff, Marc van der Valk, Marit J. van Gils, Neeltje A. Kootstra, Peter Reiss
Format: Article
Langue:English
Publié: American Society for Microbiology 2023-06-01
Collection:Microbiology Spectrum
Sujets:
HIV
SARS-CoV-2 vaccines
humoral immune responses
cellular immune responses
Accès en ligne:https://journals.asm.org/doi/10.1128/spectrum.01155-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.01155-23

Documents similaires